Evaluation and validation of diagnostic tests for guiding therapeutic decisions.

  title={Evaluation and validation of diagnostic tests for guiding therapeutic decisions.},
  author={Paul Landais and Val{\'e}rie M{\'e}resse and J C Ghislain},
  volume={64 3},
The term "theranostics" characterizes a particular combination of the coupled use of a drug therapy with a diagnostic test (called "companion diagnostics"). The diagnostic test marks out the technical means used to identify a biomarker which allows for adjusting the use of the new drug.Theranostics promise a significant step forward for the use of personalized medicine, better tailored for patients in terms of efficacy and tolerance. The development process of theranostics is complex since it… CONTINUE READING

From This Paper

Figures, tables, and topics from this paper.


Publications referenced by this paper.
Showing 1-10 of 18 references

KRAS status and efficacy in the firstline treatment of patients with metastatic colorectal cancer (mCRC) treated with FOLFIRI with or without cetuximab: the CRYSTAL experience

E Van Cutsem, I Lang, G D’haens
Journal of Clinical Oncology, • 2008
View 1 Excerpt

Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology • 2008
View 1 Excerpt

Similar Papers

Loading similar papers…